• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia?

作者信息

Storb R

机构信息

Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle 98109-1024, USA.

出版信息

Leukemia. 2001 Apr;15(4):662-3. doi: 10.1038/sj.leu.2402034.

DOI:10.1038/sj.leu.2402034
PMID:11368372
Abstract
摘要

相似文献

1
Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia?非清髓性预处理方案：对急性髓系白血病有多大相关性？
Leukemia. 2001 Apr;15(4):662-3. doi: 10.1038/sj.leu.2402034.
2
Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.基于静脉注射白消安或全身照射的清髓性预处理方案对急性髓系白血病缓解期并接受异基因造血细胞移植的儿科患者的结局比较：来自日本造血细胞移植学会的报告
Biol Blood Marrow Transplant. 2015 Dec;21(12):2141-2147. doi: 10.1016/j.bbmt.2015.08.011. Epub 2015 Aug 10.
3
The outcome of allogeneic hematopoietic cell transplantation for children with FMS-like tyrosine kinase 3 internal tandem duplication-positive acute myelogenous leukemia.FMS样酪氨酸激酶3内部串联重复阳性急性髓性白血病患儿异基因造血细胞移植的结果
Biol Blood Marrow Transplant. 2015 Jan;21(1):172-5. doi: 10.1016/j.bbmt.2014.08.008. Epub 2014 Aug 16.
4
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.缓解期急性髓系白血病的异基因造血干细胞移植：静脉用白消安加环磷酰胺（Cy）与全身照射加 Cy 作为预处理方案的比较——欧洲血液和骨髓移植学会急性白血病工作组的报告。
J Clin Oncol. 2013 Oct 1;31(28):3549-56. doi: 10.1200/JCO.2013.48.8114. Epub 2013 Aug 26.
5
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.骨髓增生异常综合征或伴有多系发育异常的急性髓性白血病患者的清髓性与非清髓性异基因移植：一项回顾性分析
Leukemia. 2006 Jan;20(1):128-35. doi: 10.1038/sj.leu.2404010.
6
Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses.在氟达拉滨/全身照射预处理方案中加入10天的地西他滨是可行的，并可诱导肿瘤相关抗原特异性T细胞反应。
Biol Blood Marrow Transplant. 2016 Jun;22(6):1000-1008. doi: 10.1016/j.bbmt.2016.02.003. Epub 2016 Feb 6.
7
Is there an association between total-body irradiation and secondary acute myelogenous leukemia/myelodysplastic syndrome in patients with relapsed/refractory Hodgkin's disease treated with autologous stem-cell transplantation?在接受自体干细胞移植治疗的复发/难治性霍奇金淋巴瘤患者中，全身照射与继发性急性髓系白血病/骨髓增生异常综合征之间是否存在关联？
J Clin Oncol. 2001 Aug 1;19(15):3585-8. doi: 10.1200/JCO.2001.19.15.3585.
8
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.接受异基因造血细胞移植的急性髓系白血病或骨髓增生异常综合征患者基于合并症和疾病状态的结局风险分层
J Clin Oncol. 2007 Sep 20;25(27):4246-54. doi: 10.1200/JCO.2006.09.7865. Epub 2007 Aug 27.
9
[Nonmyeloablative allogeneic stem cell transplantation for a 70-year-old woman with relapsed acute myelogenous leukemia].[非清髓性异基因干细胞移植治疗一名70岁复发急性髓性白血病女性]
Rinsho Ketsueki. 2004 Feb;45(2):167-9.
10
[Allogeneic hematopoietic stem cell transplantation with fludarabine, melphalan, and total body irradiation as a conditioning for elderly patients with myeloid malignancies].以氟达拉滨、美法仑及全身照射为预处理方案的异基因造血干细胞移植用于老年髓系恶性肿瘤患者
Rinsho Ketsueki. 2012 Mar;53(3):318-22.

引用本文的文献

1
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.GVHD 的预防和治疗：EBMT-ELN 工作组关于标准化实践的建议。
Bone Marrow Transplant. 2014 Feb;49(2):168-73. doi: 10.1038/bmt.2013.107. Epub 2013 Jul 29.
2
Promising role of reduced-toxicity hematopoietic stem cell transplantation (PART-I).降低毒性的造血干细胞移植的有前景作用（PART-I）。
Stem Cell Rev Rep. 2012 Dec;8(4):1254-64. doi: 10.1007/s12015-012-9401-8.
3
Defining the intensity of conditioning regimens: working definitions.
定义预处理强度：工作定义。
Biol Blood Marrow Transplant. 2009 Dec;15(12):1628-33. doi: 10.1016/j.bbmt.2009.07.004. Epub 2009 Sep 1.
4
Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.低强度预处理方案研讨会：界定剂量范围。国际血液与骨髓移植研究中心召开的研讨会报告
Biol Blood Marrow Transplant. 2009 Mar;15(3):367-9. doi: 10.1016/j.bbmt.2008.12.497.